Categories
World

Covid-19 experimental drug undergoing trials cuts risk of hospitalisation or death by half

Covid-19 experimental drug undergoing trial cuts the risk of hospitalisation or death by about half, interim clinical trial results show. The tablet called molnupiravir was given twice a day to patients recently diagnosed with the disease. US drug-maker Merck said its results were so positive that outside monitors had asked to stop the trial early. […]